Abstract

You have accessJournal of UrologyCME1 Apr 2023MP76-13 PROSTATE ARTERY EMBOLIZATION - MULTICENTER RETROSPECTIVE EXPERIENCE OF 1000 PATIENTS WITH SHORT, MID, AND LONG TERM FOLLOW UP Shivank Bhatia, Andrew Richardson, Aneesha Maini, Hamed Jalaeian, Rohit Reddy, Kenneth Richardson, Ansh Bhatia, Hemendra Shah, and Bruce Kava Shivank BhatiaShivank Bhatia More articles by this author , Andrew RichardsonAndrew Richardson More articles by this author , Aneesha MainiAneesha Maini More articles by this author , Hamed JalaeianHamed Jalaeian More articles by this author , Rohit ReddyRohit Reddy More articles by this author , Kenneth RichardsonKenneth Richardson More articles by this author , Ansh BhatiaAnsh Bhatia More articles by this author , Hemendra ShahHemendra Shah More articles by this author , and Bruce KavaBruce Kava More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003350.13AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: To evaluate and expand upon the effectiveness and safety profile of PAE in treating BPH with LUTS or urinary retention. METHODS: 1000 patients underwent PAE for either BPH with LUTS or urinary retention from January 2014 to September 2022. Mean patient age was 70.2±9.5 years, mean prostate volume was 107.2±65.1 g, median pre-procedure IPSS, SHIM and QoL scores were 23 (IQR 18-28), 17 (IQR 10-21) and 5 (IQR 4-6), respectively. Mean PVR was 195.6±232 cc, mean PSA was 6.6±6.9 ng/dl, and mean Qmax 8.0±4.2 cc/s. 100 individuals were indwelling catheter dependent at time of PAE with an average of 127.6 days of catheter dependence prior to PAE. 781 individuals reported BPH medication usage. Patient evaluation occurred at 3-6, 12, 24, 60 and 72-month (mo) intervals post PAE. Adverse events were recorded using the Clavien-Dindo (CD) classification. Two-tailed p<0.05 was considered significant. RESULTS: Median follow up was 1027 days. 63.4% of patients had 3 months or greater follow up. Median IPSS of baseline catheter independent individuals decreased to 5, 6, 7, 3, and 6 at 3-6, 12-, 24-, 60- and 72-months post PAE, respectively (all p<0.01). Percent of non-responders (IPSS>13) are included in the Table 1. Median SHIM, mean prostate size, mean PVR, mean PSA and mean Qmax data is displayed in the Table 1. Average time to indwelling catheter independence was 25.9 days following PAE. At 3 months post PAE 29% (21/73) of individuals were catheter dependent who ultimately achieved catheter independence. 67 patients (6.7%) have required a second procedure for recurrent LUTS; 10 underwent a second PAE. BPH medication cessation, decreased medication burden, and # of individuals on α-blockers of 5α reductase inhibitors is reported in the Table 1. Self-limited frequency, urgency, and dysuria (CD grade I) postoperative symptoms occurred in 33.5% of patients. Complications of non-target embolization, urosepsis, and TIAs were seen in 3 patients each. CONCLUSIONS: PAE is a clinically effective procedure for patients LUTS and urinary retention secondary to BPH with great short-term to midterm results. Long-term outcomes including maintained LUTS relief and significant improvement in QoL continue to be promising. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e1096 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Shivank Bhatia More articles by this author Andrew Richardson More articles by this author Aneesha Maini More articles by this author Hamed Jalaeian More articles by this author Rohit Reddy More articles by this author Kenneth Richardson More articles by this author Ansh Bhatia More articles by this author Hemendra Shah More articles by this author Bruce Kava More articles by this author Expand All Advertisement PDF downloadLoading ...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.